The factors considered as trigger for the attacks in patients with familial Mediterranean fever

Size: px
Start display at page:

Download "The factors considered as trigger for the attacks in patients with familial Mediterranean fever"

Transcription

1 Rheumatol Int (2013) 33: DOI /s x ORIGINAL ARTICLE The factors considered as trigger for the attacks in patients with familial Mediterranean fever Omer Karadag Abdurrahman Tufan Veli Yazisiz Kemal Ureten Sedat Yilmaz Muhammet Cinar Ali Akdogan Hakan Erdem Mehmet Akif Ozturk Salih Pay Ayhan Dinc Received: 24 December 2011 / Accepted: 7 July 2012 / Published online: 20 July 2012 Ó Springer-Verlag 2012 Abstract Although the inflammatory cascade of familial Mediterranean fever (FMF) is partially understood, triggering factors of those attacks has not been studied well. It is supposed that physical stresses such as cold exposure, tiredness and emotional stresses could provoke attacks. This study is aimed to survey the factors regarded as triggering the attacks in patients with FMF and their relationship with MEFV gene mutations. Clinical findings and genetic mutations (consist of M694V, M694I, M680I, V726A, E148Q) of patients were recorded. Patients were questioned about cold exposure, emotional stress, tiredness, long-lasting standing, long-duration travel, starvation, high intake of food, trauma, and infection as triggering factors for the attacks with both serositis and musculoskeletal pain. The study is comprised of 275 FMF patients (male/female: 177/98). The most common triggering factors for the attacks with serositis were cold exposure (59.3 %), emotional stress (49.8 %), tiredness (40.0 %) and menstruation (33.7 % in females). Long-lasting O. Karadag V. Yazisiz S. Yilmaz M. Cinar H. Erdem S. Pay A. Dinc Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey A. Tufan (&) M. A. Ozturk Division of Rheumatology, Department of Internal Medicine, Gazi University Hospital, Besevler, Ankara, Turkey dratufan@hotmail.com K. Ureten Division of Rheumatology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey A. Akdogan Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey standing (78.8 %), long-duration travel (64.1 %) and tiredness (47.8 %) were the triggering factors for the attacks with musculoskeletal symptoms. The relationships between MEFV mutations and triggering factors were found as M694V allele with starvation, E148Q allele with high intake of food and V726A allele with long-duration travel. The attacks with serositis seem to be triggered by those factors to which whole body exposed, whereas the attacks with musculoskeletal complaints seem to be triggered by those factors to which regional or local part of body exposed. Since the number of alleles was small, a clear conclusion for a relationship between a particular gene variant and a specific trigger was not made. Keywords Familial Mediterranean fever Serositis Trigger Attack Stress Cold Introduction Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by the recurrent inflammatory febrile attacks of serosal and synovial membranes [1]. The FMF gene, which is located on the short arm of chromosome 16 and symbolized with MEFV (for MEditerranean FeVer), encodes a protein termed as pyrin or marenostrin. Pyrin is expressed mainly in neutrophils and monocytes [2]. Defective pyrin in FMF patients results in recurrent inflammatory events via an inappropriate and prolonged response to inflammatory stimuli and increased leukocyte migration to serosal sites [3]. However, how this cascade triggered is a lot more complicated and not fully understood yet. It is supposed that attacks of FMF can be triggered by various factors such as infection, trauma, psychological

2 894 Rheumatol Int (2013) 33: stress, exposure to cold [4] and menstrual cycle [5] and many others, which are still unknown. In this study, we aimed to survey a group of FMF patients to disclose the factors eliciting their attacks and investigate any association between the reported factors and detected MEFV mutations. Statistical analysis Statistical analysis was done using SPSS 11.5 for Windows. Values are shown as mean ± standard deviation (SD). Chi-square test was used for the comparison of categorical variables. Materials and methods The study protocol was approved by Local Ethics Committee of Gulhane School of Medicine, and all patients gave their informed consent. Between June 2009 and May 2010, 275 patients with FMF who fulfilled Tel-Hashomer diagnostic criteria [6] from four centers in Ankara were included in the study. Attack characteristics such as recurrent abdominal pain, fever, pleuritis, pericarditis, arthritis or arthralgia, erysipelas-like erythema, the family history for FMF and the presence of amyloidosis were noted in detail. The severity of disease was determined according to the FMF severity scoring (FSS), which includes age of onset, attack frequency, arthritis, erysipelas-like erythema, amyloidosis and daily colchicine dose [7]. Genetic test findings Genetic test results were also recorded. For the determination of MEFV variants, peripheral venous blood sample was collected in ethylenediaminetetraacetic acid (EDTA) containing tubes, and DNA is extracted by standard methods. Genetic material is screened for at least 5 common MEFV mutations: E148Q in exon 2 and M694V, M694I, M680I and V726A in exon 10. Triggering factors Patients were questioned about the factors that they consider as a trigger for their continuing attacks. To eliminate recall bias, a list of factors (cold exposure, emotional stress, tiredness, long-duration standing, long-duration travel, starvation, high intake of food, trauma and infection) were asked whether they have had experienced those in a few days preceding their attacks. We did not made any standard definition for each of those factors since the study was based on the patient s perception that a factor could provoke the attacks. Questionnaires for the attacks with serositis and musculoskeletal complaints were applied separately. Any additional factor which they strongly think as a trigger for themselves as well as individual measures to prevent an impending attack was also noted. Results Ninety-eight females and 177 males were included in the study. The mean age of the FMF patients was 28.6 ± 9.4 (range 17 58) years. The patients disease characteristics are summarized in Table 1. More than 95 % of patients had fever and peritonitis during attacks. Three out of four patients had had at least one musculoskeletal complaint. Half of the patients had mild disease severity (Table 2). Cold exposure was the most common trigger experienced before a serositis attack (59.3 %). Other frequent triggers were emotional stress, tiredness and menstruation for females (Table 3). Musculoskeletal attacks were mostly triggered by long-duration standing. Other triggers for musculoskeletal attacks were long-duration travel, tiredness and cold exposure (Table 4). Patients reported avoidance from the activities or situations which they consider as a trigger. Moreover, 16 % of patients described non-steroidal Table 1 Demographic and disease features of FMF patients n = 275 Gender, (female/male) 98/177 Age, years (mean ± SD) 28.6 ± 9.4 Age at the attack onset, years (mean ± SD) 14.0 ± 9.1 Age at the diagnosis, years (mean ± SD) 20.1 ± 11.2 Family history of FMF, n (%) 106 (38.5) Amyloidosis, n (%) 8 (2.9) Table 2 Attack features and disease severity among 275 FMF patients Fever 95.9 Peritonitis 96.7 Pleuritis and/or pericarditis 55.0 Arthritis 41.0 Any musculoskeletal attack including arthritis 78.9 Erysipelas-like erythema 25.6 FMF severity Mild 50.6 Moderate 32.9 Severe 16.5 Frequency (%)

3 Rheumatol Int (2013) 33: Table 3 Triggering factors noted prior to the attacks characterized with serositis Factor Frequency (%) Cold exposure 59.3 Psychological stress 49.8 Tiredness 40.0 Menstruation, female (n = 98) 33.7 Sleeplessness 14.9 Long-lasting standing 14.5 High intake of food 10.9 Starvation 7.3 Long-duration travel 9.8 Infection 4.0 Trauma 1.5 Table 4 Triggering factors noted prior to the attacks characterized with musculoskeletal pain Factor Frequency (%) Long-lasting standing 78.8 Long-duration travel 64.1 Tiredness 47.8 Cold exposure 35.4 Psychological stress 19.5 Sleeplessness 8.8 Trauma 1.8 Table 5 Distribution of detected MEFV mutations M694V 210 (60.4) M680I 47 (13.5) V726A 23 (6.6) E148Q 11 (6.0) Number of alleles n (%) anti-inflammatory drug (NSAID) use during the exposure of any unpreventable cause to preclude or abrogate an imminent attack. Other reported preventive measures were increasing fluid intake and having a warm bath. Genetic analysis was available for 174 patients. Seventy-eight (44.8 %) of them had homozygous, 55 (31.6 %) had compound heterozygous, 40 (23.0 %) had heterozygous mutation and 1 (0.6 %) had no mutation. Distribution of alleles was shown in Table 5. For the attacks with serositis, no relationship between trigger factors and genetic findings was found except for the tiredness (p \ 0.05) in patients with homozygous mutation (Table 6). On the other hand, for the attacks with musculoskeletal type, no association was found among the trigger factors and mutation findings. Table 6 Associations between the trigger factors and genetic findings Factor In the subgroup analysis of individual mutations and triggers, starvation has been reported frequently by the patients with M694V allele (p = 0.032). Similarly, high intake of food in patients with E148Q allele (p \ 0.001) and travel in patients with V726A allele (p = 0.01) were noted commonly as a trigger. In the comparison of FMF severity subgroups with mild, moderate or severe disease, no difference was found with respect to the triggering factors. Discussion Homozygous n = 78 (%) Compound heterozygous n = 55 (%) Heterozygous n = 40 (%) Cold exposure 52 (66.7) 32 (58.1) 21 (52.5) Psychological 39 (50.0) 30 (54.5) 19 (47.5) stress Tiredness* 43 (55.1) 18 (32.7) 15 (37.5) Menstruation, female (n = 98) 6 (37.5) 8 (38.0) 2 (14.2) High intake of 8 (10.3) 9 (16.3) 4 (10.0) food Starvation 7 (8.9) 2 (3.6) 1 (2.5) Long-lasting 15 (19.2) 7 (12.7) 5 (12.5) standing Sleeplessness 18 (23.1) 8 (14.5) 6 (15.0) Long-duration 12 (15.4) 3 (5.5) 3 (7.5) travel Infection 1 (1.3) 3 (5.5) 2 (5.0) Trauma 1 (1.3) 1 (1.8) 1 (2.5) * p \ 0.05 The classic clinical picture of FMF consists of recurrent febrile serositis and/or musculoskeletal symptoms. These episodes are usually with acute onset, variable frequency and with/without a recognized triggering factor [8]. It has been proposed that FMF attacks are the result of a failure of a balance, so that a minor inflammatory trigger can stimulate a robust response. But the concept of the triggers for FMF attacks is not very well understood. We questioned FMF patients about the trigger factors for the attacks both with serositis features or musculoskeletal pain. According to our study, the most common triggering factor for serositis-type attacks (59.3 %) was cold exposure, and longduration standing for musculoskeletal type attacks. The nature of triggers for the attacks with serositis seemed to affect the body more generally systemically rather than regionally, such as cold exposure, emotional

4 896 Rheumatol Int (2013) 33: stress, tiredness and menstruation for the females. Although, formerly, infection and trauma has been proposed as possible triggers [4], it was not found to be a common factor in our study. Cold exposure was the leading triggering factor for FMF. Due to lacking information about the direct or indirect effect of cold on inflammatory mechanisms, we could not speculate on that. Emotional stress was found to be a trigger factor in about half of our patients. This result was concordant with the previous study of Gidron et al. [9] in which they had showed relationship between psychosocial factors and incidence of FMF attacks. In a recent study, the number of attacks was positively correlated with the mean depression and anxiety scores of the FMF patients [10]. Ackerman et al. [11] had found an increase in macrophage-derived cytokines IL-1 beta, TNF-alpha and Th1 lymphocyte-derived IFN-gamma production but no change in the Th2 lymphocyte-derived cytokine IL-4 after asking to give a 5-min videotaped speech defending themselves in a hypothetical scenario in which they were wrongly accused of stealing. Maes et al. [12] had reported increments in the production of the pro-inflammatory cytokines and decrements in the immuno-regulatory cytokines during the homeostatic responses to psychological stress and that stress-induced anxiety is related to a T-helper-1-like response. Therefore, emotional psychological conditions might trigger FMF attacks by increasing proinflammatory cytokine levels. Tiredness was reported as a trigger for the attacks both with serositis and musculoskeletal pain. However, tiredness would be a part of FMF attack and could have seen during or after the attack. Clinical observation has shown that familial Mediterranean fever attacks may be preceded by menstruation. Previous studies had reported 7 15 % of patients with FMF had menstruation-associated familial Mediterranean fever attacks [5, 13]. One-third of our female patients had experienced peri-menstrual attacks. It is proposed that hormonal changes may lead to the FMF attacks during menstruation [13]. Because estrogen level decreases significantly in menstruation, it can be speculated that protective effect of estrogen may disappear leading to the acute attack. Another hypothesis may be suggested based upon the finding that colchicine and estrogens are substrates of the same cytochrome (3A4) in the liver [14]. When the levels of estrogens are decreased (during menstruation), more enzymes are available for colchicine metabolism, thereby decreasing its concentration and its protective effect. Yet, these speculations do not explain why only a group of patients experience the attacks during menstruation and suggests that other factors also may take place in this period. Although high intake of food was supposed to be a predisposing factor, in our study, both starvation and high intake of food seemed to be a trigger in about 10 % of patients. But it does not have enough power to classify them as a triggering factor; this may originate from that those are ill-defined and subjective situations. Attacks with musculoskeletal pain were mostly triggered by long-lasting standing. Other triggers for this kind of symptoms were long-duration travel and tiredness. Previously we had published non-periodic (at the attackfree periods) leg pain in patients with familial Mediterranean fever [15]. That study was based on the observation that leg complaints after prolonged standing or sitting, or both, in FMF patients, who usually experience these painful manifestations during evenings or after long-distance bus trips. This type of triggers may result in some inflammatory response involving lower extremities after sustained positioning extremity in an upright position. Generally, musculoskeletal complaints had been predisposed by regional local stressors. Probably, the inflammatory reaction is initiated in a stressful microenvironment caused by not only microtrauma but also increased local hydrostatic pressure. Long-lasting walking is not reported to be a trigger factor while long-lasting standing is; that is why we suggest not only physical stress but also local hydrostatic changes might be important in such circumstances. Hence, the effect of cold on the hydrostatic and circulatory mechanisms would also be determined to make a clear conclusion about the means of cold to trigger the attacks. Except tiredness, no difference was found for other factors, between patients with homozygous and heterozygous mutations. But in the subgroup analysis of individual mutations, starvation has been commonly regarded as a factor in patients with M694V allele (p = 0.032). Although high intake of food (E148Q) and long-duration travel (V726A) were also found to be related, the number of alleles was small to make a clear conclusion. A well-known factor for attack occurrence is colchicine withdrawal. We do not include it as a trigger factor since it is not regarded as trigger factor; instead, it creates a status by which a factor may exert its trigger action more easily. On the other hand, trigger factors do not differ between patient severity subgroups. The main limitation of the present study is its retrospective design and based on patients recall ability. Also it is a subjective but a general consideration of an individual patient about her or his attacks. Every patient s conclusion was derived from nearly all attacks experienced in his or her past history. This may strengthen the value of those factors as a cause to initiate the attacks. Our results reflect only adult FMF patients to evaluate candidate triggers in a retrospective data collection method. A prospective design may disclose additional trigger factors and the relationship between those factors and the severity of resultant attacks.

5 Rheumatol Int (2013) 33: As a conclusion, the body s inflammation system must be wired for balance; it must respond vigorously and systemically to a meaningful insult (e.g., cold, emotional stress or tiredness). The attacks with serositis seem to be triggered by those factors to which whole body exposed, whereas the attacks with musculoskeletal complaints seem to be triggered by those factors to which regional or local part of body exposed. Patient-reported evidence suggests that NSAIDs could be used to prevent an impending attack. Conflict of interest References None of authors declare any conflict of interest. 1. Livneh A, Langevitz P (2000) Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14: Ozen S (2003) Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 162(7 8): Bhat A, Naguwa SM, Gershwin ME (2007) Genetics and new treatment modalities for familial Mediterranean fever. Ann N Y Acad Sci 1110: Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, La Regina M, Gasbarrini G, Manna R (2009) Familial Mediterranean fever: a review for clinical management. Joint Bone Spine 76(3): Ben-Chetrit E, Ben-Chetrit A (2001) Familial Mediterranean fever and menstruation. BJOG 108(403):e7 6. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10): Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 35(1): Makay B, Unsal E (2009) Altered circadian rhythm: possible trigger of familial Mediterranean fever attacks. Med Hypotheses 73: Gidron Y, Berkovitch M, Press J (2003) Psychosocial correlates of incidence of attacks in children with Familial Mediterranean Fever. J Behav Med 26(2): Makay B, Emiroğlu N, Unsal E (2010) Depression and anxiety in children and adolescents with familial Mediterranean fever. Clin Rheumatol 29(4): Ackerman KD, Martino M, Heyman R, Moyna NM, Rabin BS (1998) Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med 60(4): Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10(4): Golden RL, Weigers EW, Meagher JG (1973) Periodic fever and menses. Am J Obstet Gynecol 117: Ben-Chetrit E, Levy M (2003) Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 62(10): Dinç A (2000) Non-period leg pain in patients with familial Mediterranean fever. Ann Rheum Dis 59(5):400

FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD

FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD FMF Is a hereditary autoinflammatory disease caused by mutations in Mediterranean fever gene (MEFV). It is inherited in an autosomal recessive

More information

E148Q as A Familial Mediterranean Fever-Causing Mutation: A Clinical-Based Study R A Jarjour ABSTRACT

E148Q as A Familial Mediterranean Fever-Causing Mutation: A Clinical-Based Study R A Jarjour ABSTRACT E148Q as A Familial Mediterranean Fever-Causing Mutation: A Clinical-Based Study R A Jarjour ABSTRACT Objective: to evaluate the clinical implications of E148Q mutation in familial Mediterranean fever

More information

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS Stage I: Rule-Out Dashboard HGNC ID: 6998 OMIM ID: 134610 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does

More information

Adult-Onset Familial Mediterranean Fever in Northwestern Iran; Clinical Feature and Treatment Outcome

Adult-Onset Familial Mediterranean Fever in Northwestern Iran; Clinical Feature and Treatment Outcome 50 Original Article Adult-Onset Familial Mediterranean Fever in Northwestern Iran; Clinical Feature and Treatment Outcome H Nobakht 1, F Zamani 2, H Ajdarkosh 3, Z Mohamadzadeh 4, SM Fereshtehnejad 5,

More information

Evaluation of Restless Legs syndrome and growing pains in children with familial Mediterranean fever

Evaluation of Restless Legs syndrome and growing pains in children with familial Mediterranean fever The Turkish Journal of Pediatrics 2018; 60: 159-164 DOI: 10.24953/turkjped.2018.02.007 Evaluation of Restless Legs syndrome and growing pains in children with familial Mediterranean fever Özge Altuğ-Gücenmez,

More information

Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study

Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study Ben-Zvi et al. Orphanet Journal of Rare Diseases 2014, 9:3 RESEARCH Open Access Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study

More information

The role of E148Q in FMF. Elon Pras Institute of Human Genetics Sheba Medical Center

The role of E148Q in FMF. Elon Pras Institute of Human Genetics Sheba Medical Center The role of E148Q in FMF Elon Pras Institute of Human Genetics Sheba Medical Center Familial Mediterranean Fever (FMF) Acute attacks of fever accompanied by: Peritonitis Pleuritis Arthritis Erysipelas

More information

MEFV Mutations and CYP3A4 Polymorphisms Do Not Predict Colchicine Responsiveness in Familial Mediterranean Fever

MEFV Mutations and CYP3A4 Polymorphisms Do Not Predict Colchicine Responsiveness in Familial Mediterranean Fever Kamla-Raj 2014 Int J Hum Genet, 14(1): 27-32 (2014) MEFV Mutations and CYP3A4 Polymorphisms Do Not Predict Colchicine Responsiveness in Familial Mediterranean Fever Tayfun Akalin 1, Seminur Haznedaroglu

More information

Clinical Study Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

Clinical Study Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever International Rheumatology Volume 2016, Article ID 7354018, 6 pages http://dx.doi.org/10.1155/2016/7354018 Clinical Study Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever Hala

More information

RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION

RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION PROCEEDINGS OF THE YEREVAN STATE UNIVERSITY C h e m i s t r y a n d B i o l o g y 2016, 3, p. 48 52 RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION B i o l o g y H. S. HAYRAPETYAN

More information

Diagnosis delay in familial Mediterranean fever (FMF): Social and gender gaps disclosed

Diagnosis delay in familial Mediterranean fever (FMF): Social and gender gaps disclosed Diagnosis delay in familial Mediterranean fever (FMF): Social and gender gaps disclosed M. Lidar, I. Tokov, A. Chetrit 1, N. Zaks, P. Langevitz, A. Livneh Heller Institute of Medical Research, and 1 Gertner

More information

Background 11/8/2011. Disclosure. Hereditary Periodic Fever Syndromes Mutations in Idiopathic Acute Recurrent Pericarditis.

Background 11/8/2011. Disclosure. Hereditary Periodic Fever Syndromes Mutations in Idiopathic Acute Recurrent Pericarditis. Mutations in Idiopathic Acute Recurrent Pericarditis Disclosure I have no relevant financial relationships to disclose Guillaume Geri, Pierre Hausfater, Catherine Dodé, Zahir Amoura, Jean-Charles Piette,

More information

Gastrointestinal evaluation in colchicine-treated familial Mediterranean fever patients with chronic abdominal pain: Cases series

Gastrointestinal evaluation in colchicine-treated familial Mediterranean fever patients with chronic abdominal pain: Cases series Case report Arch Argent Pediatr 2018;116(5):e649-e654 / e649 Gastrointestinal evaluation in colchicine-treated familial Mediterranean fever patients with chronic abdominal pain: Cases series Sezin Akman

More information

Familial Mediterranean Fever. By:Ismaeel Qattam

Familial Mediterranean Fever. By:Ismaeel Qattam Familial Mediterranean Fever By:Ismaeel Qattam FMF : It s characterized by auto inflammatory condition that causes recurrent fevers and painful inflammation of the abdomen, lungs, joints, etc. It s an

More information

Familial Mediterranean fever without MEFV mutations: a case control study

Familial Mediterranean fever without MEFV mutations: a case control study Ben-Zvi et al. Orphanet Journal of Rare Diseases (2015) 10:34 DOI 10.1186/s13023-015-0252-7 RESEARCH Familial Mediterranean fever without MEFV mutations: a case control study Open Access Ilan Ben-Zvi 1,2,3,4,5*,

More information

Acute Pericarditis as the First Manifestation of Familial Mediterranean Fever: A Possible Relationship with Idiopathic Recurrent Pericarditis

Acute Pericarditis as the First Manifestation of Familial Mediterranean Fever: A Possible Relationship with Idiopathic Recurrent Pericarditis CASE REPORT Acute Pericarditis as the First Manifestation of Familial Mediterranean Fever: A Possible Relationship with Idiopathic Recurrent Pericarditis Katsunobu Yoshioka 1, Yutaka Furumitsu 2, Tatsushi

More information

This is a refereed journal and all articles are professionally screened and reviewed

This is a refereed journal and all articles are professionally screened and reviewed Advances in Environmental Biology, 6(11): 2894-2900, 2012 ISSN 1995-0756 2894 This is a refereed journal and all articles are professionally screened and reviewed ORIGINAL ARTICLE MEFV gene mutations in

More information

Assesment life quality of familial mediterranean fever patients by short form-36 and its relationship with disease parameters

Assesment life quality of familial mediterranean fever patients by short form-36 and its relationship with disease parameters European Review for Medical and Pharmacological Sciences Assesment life quality of familial mediterranean fever patients by short form-36 and its relationship with disease parameters S. SAHIN 1, I. YALCIN

More information

paediatric rheumatologist evaluate the frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever

paediatric rheumatologist evaluate the frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever Paediatric rheumatology The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever E. Ozer, D. Seker, E. Taner, A. Adrovic, S. Sahin, K. Barut, O. Kasapçopur Department of

More information

Case report. Yasutsugu Fukushima, 1 Kazuki Obara, 1 Hirokuni Hirata, 1 Kumiya Sugiyama, 1 Takeshi Fukuda 1 and Kazuhiko Takabe 2

Case report. Yasutsugu Fukushima, 1 Kazuki Obara, 1 Hirokuni Hirata, 1 Kumiya Sugiyama, 1 Takeshi Fukuda 1 and Kazuhiko Takabe 2 Case report Three Japanese patients (mother and two children) with familial Mediterranean fever associated with compound heterozygosity for // and an autosomal true dominant inheritance pattern Yasutsugu

More information

hereditary periodic fever periodic fever syndrome recurrent fever familial Mediterranean FMF autoinflammatory syndrome T 1 Tsutomu Oh-ishi

hereditary periodic fever periodic fever syndrome recurrent fever familial Mediterranean FMF autoinflammatory syndrome T 1 Tsutomu Oh-ishi Vol. 20 No. 3331 1 FMFTNF TRAPS IgD HIDSCAPS FMF recurrent fever autoinflammatory syndrome T 1,2 1 1 hereditary periodic fever periodic fever syndrome 3 familial Mediterranean fever FMF 4 1 Key wordsmefv

More information

Familial Mediterranean Fever

Familial Mediterranean Fever Familial Mediterranean Fever FMF most often occurs in individuals of Mediterranean and Middle Eastern descent, and the first episodes typically begin in childhood Fast Facts FMF causes episodic fevers

More information

Familial Mediterranean Fever in a Sample of Iraqi Patients

Familial Mediterranean Fever in a Sample of Iraqi Patients FAMILIAL THE IRAQI MEDITERRANEAN POSTGRADUATE FEVER MEDICAL JOURNAL VOL.6, NO.2, 2007 Familial Mediterranean Fever in a Sample of Iraqi Patients Ali Abdul Kadhim Al Sultany ABSTRACT: BACKGROUND: Up to

More information

Pediatric rheumatology review. New interest in an old disease: Familial Mediterranean fever

Pediatric rheumatology review. New interest in an old disease: Familial Mediterranean fever Paraneoplastic RS3PE / F. Cantini et al. Pediatric rheumatology review SHORT REVIEW New interest in an old disease: Familial Mediterranean fever S. Ozen Seza Ozen, MD, Associate Professor, Department of

More information

Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever

Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever Case report Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever Akinori Nakamura Masayuki Matsuda Ko-ichi Tazawa Yasuhiro Shimojima Shu-ichi

More information

ATHEROSCLEROSIS AMONG PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER ROLE OF COLCHICINOTHERAPY

ATHEROSCLEROSIS AMONG PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER ROLE OF COLCHICINOTHERAPY 4th Eastern European Conference on Rare Diseases and Orphan Drugs 13-14 June 2009 in Plovdiv, Bulgaria. ATHEROSCLEROSIS AMONG PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER ROLE OF COLCHICINOTHERAPY Poster

More information

Ministry of Health, Samsun, Turkey, c Department of Medical Genetics, Samsun Training and Research Hospital, Ministry of

Ministry of Health, Samsun, Turkey, c Department of Medical Genetics, Samsun Training and Research Hospital, Ministry of This article was downloaded by: [University of Washington Libraries] On: 27 August 2015, At: 11:31 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered

More information

MEFV mutation analysis of familial Mediterranean fever in Japan

MEFV mutation analysis of familial Mediterranean fever in Japan MEFV mutation analysis of familial Mediterranean fever in Japan N. Tomiyama 1, Y. Higashiuesato 1, T. Oda 2, E. Baba 4, M. Harada 4, M. Azuma 5, T. Yamashita 6, K. Uehara 7, A. Miyazato 8, K. Hatta 9,

More information

Total pathogenic allele frequency of autosomal recessive MEFV mutations causing familial Mediterranean fever in Tunisia and Morocco

Total pathogenic allele frequency of autosomal recessive MEFV mutations causing familial Mediterranean fever in Tunisia and Morocco CHAPTER 7 Total pathogenic allele frequency of autosomal recessive MEFV mutations causing familial Mediterranean fever in Tunisia and Morocco Teeuw ME/ Kelmemi W, Jonker MA, Kharrat M, Lariani I, Laarabi

More information

Spectrum of Mutations of Familial Mediterranean Fever Gene in Iranian Population

Spectrum of Mutations of Familial Mediterranean Fever Gene in Iranian Population Research Article Spectrum of Mutations of Familial Mediterranean Fever Gene in Iranian Population Tayebeh Sabokbar 1,2, Ali Malayeri 2, Cyrus Azimi 2, Seyyed Reza Raeeskarami 3,4, Vahid Ziaee 3,4, Yahya

More information

Misdiagnosis of familial Mediterranean fever in patients with Anderson Fabry disease

Misdiagnosis of familial Mediterranean fever in patients with Anderson Fabry disease Clin Genet 2013: 83: 576 581 Printed in Singapore. All rights reserved Short Report 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd CLINICAL GENETICS doi: 10.1111/j.1399-0004.2012.01940.x

More information

Five Cases of Familial Mediterranean Fever in Japan: The Relationship with MEFV Mutations

Five Cases of Familial Mediterranean Fever in Japan: The Relationship with MEFV Mutations doi: 10.2169/internalmedicine.0057-17 http://internmed.jp CASE REPORT Five Cases of Familial Mediterranean Fever in Japan: The Relationship with MEFV Mutations Kazuki Kimura 1,2, Masafumi Mizooka 2, Kiyoshi

More information

Polyarteritis nodosa in case of familial Mediterranean fever

Polyarteritis nodosa in case of familial Mediterranean fever The Turkish Journal of Pediatrics 2018; 60: 326-330 DOI: 10.24953/turkjped.2018.03.016 Polyarteritis nodosa in case of familial Mediterranean fever İbrahim Gökçe 1, Ülger Altuntaş 1, Deniz Filinte 2, Harika

More information

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress AUTO-INFLAMMATORY (HYPER-INFLAMMATORY) SYNDROMES AN UPDATE Dr. John M. Angles BVSc, BSc(Vet), MVS, PhD, MACVSc,

More information

Introduction. Keywords: AA amyloidosis; TNFRSF1A; MEFV; NALP3; periodic fever

Introduction. Keywords: AA amyloidosis; TNFRSF1A; MEFV; NALP3; periodic fever (2004) 5, 289 293 & 2004 Nature Publishing Group All rights reserved 1466-4879/04 $30.00 www.nature.com/gene FULL PAPER Allelic variants in genes associated with hereditary periodic fever syndromes as

More information

Familial Mediterranean Fever

Familial Mediterranean Fever www.printo.it/pediatric-rheumatology/gb/intro Familial Mediterranean Fever Version of 2016 1. WHAT IS FMF 1.1 What is it? Familial Mediterranean Fever (FMF) is a genetically transmitted disease. Patients

More information

Current trends in colchicine treatment in. in familial Mediterranean fever

Current trends in colchicine treatment in. in familial Mediterranean fever Current trends in colchicine treatment in familial Mediterranean fever M. La Regina 1, E. Ben-Chetrit 2, A.Y. Gasparyan 3, A. Livneh 4, H. Ozdogan 5, R. Manna 1 1 Periodic Fevers Research Centre, Catholic

More information

Familial Mediterranean Fever. For. Professor Brutlag BIO84 16 March 2011

Familial Mediterranean Fever. For. Professor Brutlag BIO84 16 March 2011 Familial Mediterranean Fever For Professor Brutlag BIO84 16 March 2011 2 Three months ago, I received the results are ready e-mail I had been eagerly anticipating since the moment I spit into that infamous

More information

Cases from the Clinic Maryland ACP Meeting January 30, 2016

Cases from the Clinic Maryland ACP Meeting January 30, 2016 Cases from the Clinic Maryland ACP Meeting January 30, 2016 Bimal Ashar, MD, FACP D. William Schlott, MD Associate Professor of Medicine Johns Hopkins University School of Medicine 1 CASE 1: GK 46-year-old

More information

Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran

Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran The Turkish Journal of Pediatrics 2008; 50: 40-44 Original Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran Farhad Salehzadeh 1, Dina Emami 1, Ali Asgar Zolfegari

More information

The rise and fall of FMF research Fifty years of publications

The rise and fall of FMF research Fifty years of publications Clinical and Experimental Rheumatology 2005; 23: S3-S7. The rise and fall of FMF research Fifty years of publications Eli Ben-Chetrit 1, Eldad Ben-Chetrit 1 Department of Medicine, Shaare Zedek Medical

More information

Centre for Arab Genomic Studies A Division of Sheikh Hamdan Award for Medical Sciences

Centre for Arab Genomic Studies A Division of Sheikh Hamdan Award for Medical Sciences Centre for Arab Genomic Studies A Division of Sheikh Hamdan Award for Medical Sciences The Catalogue for Transmission Genetics in Arabs CTGA Database Familial Mediterranean Fever Alternative Names FMF

More information

Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell

Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell Wenxin Li Department of Biological Sciences Fordham University Abstract MEFV is a human gene that codes for an

More information

A761H, A744S, V726A, K695R, M694V, M694I,

A761H, A744S, V726A, K695R, M694V, M694I, (2001) 9, 51 55 2001 Macmillan Publishers Ltd All rights reserved 1018 4813/01 $15.00 y www.nature.com/ejhg SHORT REPORT Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in

More information

Familial Mediterranean fever

Familial Mediterranean fever Familial Mediterranean fever Is a hereditary autoinflammatory disorder characterized by recurrent bouts of fever and serosal inflammation. The initial attack occurs before the ages of 10 and 20 years in

More information

Disease Current Activity Form

Disease Current Activity Form Patient-driven assessment of disease activity in Behçet s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet s Syndrome Activity Score S. Yilmaz 1, I. Simsek

More information

Umbrella study design in patients with Hereditary Periodic Fevers, an orphan autoimmune disease. Karine Lheritier 15 June 2016 PSI Immunology meeting

Umbrella study design in patients with Hereditary Periodic Fevers, an orphan autoimmune disease. Karine Lheritier 15 June 2016 PSI Immunology meeting Umbrella study design in patients with Hereditary Periodic Fevers, an orphan autoimmune disease Karine Lheritier 15 June 2016 PSI Immunology meeting Outline Hereditary Periodic Fevers Canakinumab Study

More information

Familial Mediterranean fever: clinical, molecular and management advancements

Familial Mediterranean fever: clinical, molecular and management advancements REVIEW Familial Mediterranean fever: clinical, molecular and management advancements M. Lidar *, A. Livneh Heller Institute of Medical Research, Sheba Medical Centre, Tel-Hashomer, affiliated with the

More information

Familial Mediterranean fever (FMF) is an autosomal recessive

Familial Mediterranean fever (FMF) is an autosomal recessive Familial Mediterranean Fever Genotype-Phenotype Correlations in Japanese Patients Kiyoshi Migita, MD, PhD, Kazunaga Agematsu, MD, PhD, Masahide Yazaki, MD, PhD, Fumiaki Nonaka, MD, PhD, Akinori Nakamura,

More information

A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy

A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy DOI: 10.1111/eci.12783 ORIGINAL ARTICLE A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy Leonilde Bonfrate *, Giuseppe Scaccianoce, Giuseppe Palasciano *, Eldad Ben-Chetrit

More information

Frequency of mutations in Mediterranean fever gene, with gender and genotype phenotype correlations in a Turkish population

Frequency of mutations in Mediterranean fever gene, with gender and genotype phenotype correlations in a Turkish population c Indian Academy of Sciences RESEARCH ARTICLE Frequency of mutations in Mediterranean fever gene, with gender and genotype phenotype correlations in a Turkish population SALIH COŞKUN 1,5, SERKAN KURTGÖZ

More information

Pedido de acesso a dados do Registo Nacional de Doentes Reumáticos (Reuma.pt) da Sociedade Portuguesa de Reumatologia

Pedido de acesso a dados do Registo Nacional de Doentes Reumáticos (Reuma.pt) da Sociedade Portuguesa de Reumatologia Pedido de acesso a dados do Registo Nacional de Doentes Reumáticos (Reuma.pt) da Sociedade Portuguesa de Reumatologia 1. Title Autoinflammatory Diseases: analysis based on The Rheumatic Diseases Portuguese

More information

Autoinflammatory Diseases in Pediatrics

Autoinflammatory Diseases in Pediatrics 1 2 3 4 5 Autoinflammatory Diseases in Pediatrics Q2Q3 Jonathan S. Hausmann, MD*, Fatma Dedeoglu, MD Q4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

More information

Basic Ultrasound Course in Belek near Antalya, Turkey. April 25-27, Programme

Basic Ultrasound Course in Belek near Antalya, Turkey. April 25-27, Programme Basic Ultrasound Course in Belek near Antalya, Turkey April 25-27, 2019 Programme Venue: Xanadu Hotel, Belek, Antalya,Turkey Course fee including course registration, hotel for 3 nights & meals: 950 Number

More information

Bone Mineral Density in Egyptian Children with Familial Mediterranean Fever

Bone Mineral Density in Egyptian Children with Familial Mediterranean Fever IJMS Vol 41, No 1, January 2016 Original Article Bone Mineral Density in Egyptian Children with Familial Mediterranean Fever Samia Salah 1, MD; Sahar A El-Masry 2, PhD; Hala Fathy Sheba 3, MD; Rokia A

More information

Assesment of Common Exon 10 MEFV Gene Mutations in Patients with Refractory Rheumatoid Arthritis

Assesment of Common Exon 10 MEFV Gene Mutations in Patients with Refractory Rheumatoid Arthritis Archives of Orthopedics and Rheumatology Volume 1, Issue 1, 2018, PP: 1-6 Assesment of Common Exon 10 MEFV Gene Mutations in Patients with Refractory Rheumatoid Arthritis Abbas Mirzaei 1 *, Sousan Kolahi

More information

Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever

Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever Rheumatol Int (2012) 32:1955 1962 DOI 10.1007/s00296-011-1894-y ORIGINAL ARTICLE Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever Ilker Kemal Yucel Emire Seyahi Ozgur Kasapcopur

More information

TNF Receptor Associated Periodic Syndrome (TRAPS)

TNF Receptor Associated Periodic Syndrome (TRAPS) https://www.printo.it/pediatric-rheumatology/gb/intro TNF Receptor Associated Periodic Syndrome (TRAPS) Version of 2016 1. WHAT IS TRAPS 1.1 What is it? TRAPS is an inflammatory disease characterised by

More information

Research Article Familial Mediterranean Fever in Iran: A Report from FMF Registration Center

Research Article Familial Mediterranean Fever in Iran: A Report from FMF Registration Center International Rheumatology Volume 2015, Article ID 912137, 6 pages http://dx.doi.org/10.1155/2015/912137 Research Article Familial Mediterranean Fever in Iran: A Report from FMF Registration Center Farhad

More information

ARTHROPATHY AMONG PATIENTS WITH BEHCET'S DISEASE IN KING HUSSEIN MEDICAL CENTER IN JORDAN

ARTHROPATHY AMONG PATIENTS WITH BEHCET'S DISEASE IN KING HUSSEIN MEDICAL CENTER IN JORDAN ARTHROPATHY AMONG PATIENTS WITH BEHCET'S DISEASE IN KING HUSSEIN MEDICAL CENTER IN JORDAN Dr. Osama Al Khataybeh, MD. Dr. Mazen Al Zo'ubi *1, MD. Nisreen AL Kurdi RN, MSN 2, RN. Dr. Mohammad Dhros 3, MD.

More information

FMF patient with Muscle Pain. Soad Haj Yahia Sheba Medical Center Tel Hashomer -Israel

FMF patient with Muscle Pain. Soad Haj Yahia Sheba Medical Center Tel Hashomer -Israel FMF patient with Muscle Pain Soad Haj Yahia Sheba Medical Center Tel Hashomer -Israel Introduction FMF Familial Mediterranean Fever -Auto inflammatory disease caused by mutations in MEFV gene. -Autosomal

More information

Dapsone as an Alternative Therapy in Children with Familial Mediterranean Fever

Dapsone as an Alternative Therapy in Children with Familial Mediterranean Fever Original Article Iran J Pediatr ar 2012; Vol 22 (No 1), Pp: 23-27 Dapsone as an Alternative Therapy in Children with amilial editerranean ever arhad Salehzadeh*, D; Sepideh Jahangiri, D, and Elnaz ohammadi,

More information

recurrent febrile syndromes what a rheumatologist needs to know

recurrent febrile syndromes what a rheumatologist needs to know recurrent febrile syndromes what a rheumatologist needs to know Hal M. Hoffman and Anna Simon abstract rheumatologists are likely to be asked to evaluate patients with recurrent febrile syndromes, so it

More information

Familial Mediterranean fever is no longer a rare disease in Japan

Familial Mediterranean fever is no longer a rare disease in Japan Migita et al. Arthritis Research & Therapy (2016) 18:175 DOI 10.1186/s13075-016-1071-5 RESEARCH ARTICLE Familial Mediterranean fever is no longer a rare disease in Japan Open Access Kiyoshi Migita 1,2*,

More information

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution

More information

are associated with sickle cell disease and carriers: a study of patients from the southeastregion of Iran

are associated with sickle cell disease and carriers: a study of patients from the southeastregion of Iran CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 are associated with sickle cell disease and carriers: a study of patients from the southeastregion of Iran Mojgan Noroozi Karimabad Molecular Medicine Research

More information

Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients

Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients Original Article Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients Ozge Basaran, Nermin Uncu, Banu Acar Celikel, Fatma Aydın, Nilgun

More information

Original Articles. Serum Vitamin B12 Status in Children with Familial Mediterranean Fever Receiving Colchicine Treatment

Original Articles. Serum Vitamin B12 Status in Children with Familial Mediterranean Fever Receiving Colchicine Treatment HK J Paediatr (new series) 2011;16:3-8 Original Articles Serum Vitamin B12 Status in Children with Familial Mediterranean Fever Receiving Colchicine Treatment R YILMAZ, S OZER, H OZYURT, U ERKORKMAZ Abstract

More information

Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment in a patient not responding to colchicine: a case report

Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment in a patient not responding to colchicine: a case report Gemilyan et al. Journal of Medical Case Reports (2018) 12:130 https://doi.org/10.1186/s13256-018-1691-2 CASE REPORT Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment

More information

Familial Mediterranean Fever [Recurrent Polyserositis. Includes: Familial Mediterranean Fever Type 1, Familial Mediterranean Fever Type 2]

Familial Mediterranean Fever [Recurrent Polyserositis. Includes: Familial Mediterranean Fever Type 1, Familial Mediterranean Fever Type 2] Familial Mediterranean Fever [Recurrent Polyserositis. Includes: Familial Mediterranean Fever Type 1, Familial Mediterranean Fever Type 2] PMID: 20301405 Mordechai Shohat, MD Director, Raphael Recanati

More information

Summary. Introduction

Summary. Introduction Am. J. Hum. Genet. 65:88 97, 1999 MEFV-Gene Analysis in Armenian Patients with Familial Mediterranean Fever: Diagnostic Value and Unfavorable Renal Prognosis of the M694V Homozygous Genotype Genetic and

More information

Evaluation of the effectiveness of colchicine therapy in preventing. renal amyloidosis in patients with Familial Mediterranean Fever

Evaluation of the effectiveness of colchicine therapy in preventing. renal amyloidosis in patients with Familial Mediterranean Fever Evaluation of the effectiveness of colchicine therapy in preventing renal amyloidosis in patients with Familial Mediterranean Fever in Yerevan, Armenia Master of Public Health Thesis Project Utilizing

More information

Digestive Diseases and Sciences, Vol. 51, No. 4 (April 2006), pp ( C 2006) DOI: /s

Digestive Diseases and Sciences, Vol. 51, No. 4 (April 2006), pp ( C 2006) DOI: /s Digestive Diseases and Sciences, Vol. 51, No. 4 (April 2006), pp. 687 692 ( C 2006) DOI: 10.1007/s10620-006-3192-1 Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Canakinumab Table of Contents Coverage Policy... 1 General Background... 3 Coding/Billing Information... 5 References... 5 Effective Date... 7/15/2017 Next

More information

Reproduction Review YOU ARE EXPECTED TO KNOW THE MEANING OF ALL THE FOLLOWING TERMS:

Reproduction Review YOU ARE EXPECTED TO KNOW THE MEANING OF ALL THE FOLLOWING TERMS: Reproduction Review YOU ARE EXPECTED TO KNOW THE MEANING OF ALL THE FOLLOWING TERMS: CHROMOSOME GENE DNA TRAIT HEREDITY INTERPHASE MITOSIS CYTOKINESIS ASEXUAL BINARY FISSION CELL CYCLE GENETIC DIVERSITY

More information

Treatment of Dysautonomia in the Joint Hypermobility Syndrome

Treatment of Dysautonomia in the Joint Hypermobility Syndrome Treatment of Dysautonomia in the Joint Hypermobility Syndrome Jaime F. Bravo, MD San Juan de Dios Hospital, Rheumatology Dept. University of Chile Medical School. Santiago, Chile Causes of Dysautonomia

More information

Familial Mediterranean Fever

Familial Mediterranean Fever https://www.printo.it/pediatric-rheumatology/gb/intro Familial Mediterranean Fever Version of 2016 2. DIAGNOSIS AND TREATMENT 2.1 How is it diagnosed? Generally the following approach is followed: Clinical

More information

Detection of MEFV- Gene Mutations in Egyptian Children with Inflammatory Bowel Disease

Detection of MEFV- Gene Mutations in Egyptian Children with Inflammatory Bowel Disease Detection of MEFV- Gene Mutations in Egyptian Children with Inflammatory Bowel Disease Thesis Submitted in the partial fulfillment of M.D.pediatrics By Yomna Mohamed Farag SUPERVISORS Prof.Dr Samia Salah

More information

Familial Mediterranean fever (FMF) is an autosomal recessive

Familial Mediterranean fever (FMF) is an autosomal recessive REVIEW Diagnosis and management of familial Mediterranean fever: Integrating medical genetics in a dedicated interdisciplinary clinic Neda Zadeh, MD 1,2, Terri Getzug, MD 3, and Wayne W. Grody, MD, PhD

More information

F amilial Mediterranean fever (FMF) is an autosomal

F amilial Mediterranean fever (FMF) is an autosomal 438 EXTENDED REPORT Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients K Ritis, S Giaglis, N Spathari,

More information

F amilial Mediterranean fever (FMF) is an autosomal

F amilial Mediterranean fever (FMF) is an autosomal 438 EXTENDED REPORT Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients K Ritis, S Giaglis, N Spathari,

More information

Renal amyloidosis in familial Mediterranean fever

Renal amyloidosis in familial Mediterranean fever Kidney International, Vol. 65 (2004), pp. 1118 1127 Renal amyloidosis in familial Mediterranean fever NEPHROLOGY FORUM Principal discussant: SEZA OZEN Department of Pediatrics, Hacettepe University, Ankara,

More information

Thoracic and lung involvement in familial Mediterranean fever (FMF)

Thoracic and lung involvement in familial Mediterranean fever (FMF) Clin Chest Med 23 (2002) 505 511 Thoracic and lung involvement in familial Mediterranean fever (FMF) Merav Lidar, MD, Mordechai Pras, MD, Pnina Langevitz, MD, Avi Livneh, MD* Heller Institute of Medical

More information

Human Chromosomes. Lesson Overview. Lesson Overview Human Chromosomes

Human Chromosomes. Lesson Overview. Lesson Overview Human Chromosomes Lesson Overview 14.1 THINK ABOUT IT If you had to pick an ideal organism for the study of genetics, would you choose one that produced lots of offspring, was easy to grow in the lab, and had a short life

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP

More information

Research Example Aliza Ben-Zacharia DrNP, ANP

Research Example Aliza Ben-Zacharia DrNP, ANP Research Example Aliza Ben-Zacharia DrNP, ANP Example - Outline Introduction Depression & MS Research Question? Hypotheses Study Design Tools/Variables Beck Depression Inventory (BDI) BDI-II BDI-Fast-Screen

More information

Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever

Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology https://doi.org/.336/jkms.6.3..9 J Korean Med Sci 6; 3: 9-96 Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever

More information

NALP12, a gene responsible for periodic fever syndromes. Isabelle Jéru INSERM U.654, Paris, FRANCE

NALP12, a gene responsible for periodic fever syndromes. Isabelle Jéru INSERM U.654, Paris, FRANCE NALP12, a gene responsible for periodic fever syndromes Isabelle Jéru INSERM U.654, Paris, FRANCE Hereditary periodic fever syndromes (HPFs) Phenotype 6 clinical entities Fever episodes Abdominal pain

More information

Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients

Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients European Review for Medical and Pharmacological Sciences Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients 2013; 17: 253-260 K. DEVECI, A.K. GOKAKIN 1,

More information

A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV Mutations

A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV Mutations doi: 10.2169/internalmedicine.1401-18 Intern Med Advance Publication http://internmed.jp CASE REPORT A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV Mutations

More information

Pattern of Acute Rheumatic Fever in a Local Teaching Hospital

Pattern of Acute Rheumatic Fever in a Local Teaching Hospital Pattern of Acute Rheumatic Fever in a Local Teaching Hospital A Omar, FRCP Department of Paediatrics, Faculty of Medicine, University of Malaya, 59700 Kuala Lumpur Introduction Acute rheumatic fever (ARF)

More information

Pathophysiologic Basis of Autoimmune Disorders

Pathophysiologic Basis of Autoimmune Disorders Pathophysiologic Basis of Autoimmune Disorders Linda Felver, Ph.D., R.N. Associate Professor School of Nursing Oregon Health & Science University The immune system has two arms: Adaptive (Acquired) Immune

More information

osteoarthritis M. Zeki Karagülle Istanbul University Istanbul Medical Faculty Department of Medical Ecology and Hydroclimatology

osteoarthritis M. Zeki Karagülle Istanbul University Istanbul Medical Faculty Department of Medical Ecology and Hydroclimatology Spa therapy for lumbar spine osteoarthritis M. Zeki Karagülle Istanbul University Istanbul Medical Faculty Department of Medical Ecology and Hydroclimatology Osteoarthritis the most common form of arthritis

More information

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science LECTURE OUTLINE CHAPTERS 16, 17, 18 AND 19

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science LECTURE OUTLINE CHAPTERS 16, 17, 18 AND 19 MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science LECTURE OUTLINE CHAPTERS 16, 17, 18 AND 19 CHAPTER 16: NONSPECIFIC DEFENSES OF THE HOST I. THE FIRST LINE OF DEFENSE A. Mechanical Barriers (Physical

More information

Immunological Aspect of Ozone in Rheumatic Diseases

Immunological Aspect of Ozone in Rheumatic Diseases Immunological Aspect of Ozone in Rheumatic Diseases Prof. Dr. med. Z. Fahmy Chief Consulting Rheumatologist Augusta Clinic for Rheumatic Diseases And Rehabilitation Bad Kreuznach Germany Rheumatoid arthritis

More information

Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals

Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals E. Ben-Chetrit 1, S. Urieli-Shoval 2, S. Calko 2, D. Abeliovich 3, Y. Matzner 2 1 Department of Medicine, 3 Department of Human

More information

Rheumatic Fever And Post-streptococcal Reactive Arthritis

Rheumatic Fever And Post-streptococcal Reactive Arthritis www.printo.it/pediatric-rheumatology/gb/intro Rheumatic Fever And Post-streptococcal Reactive Arthritis Version of 2016 1. WHAT IS RHEUMATIC FEVER 1.1 What is it? Rheumatic fever is a disease caused by

More information

The Major Histocompatibility Complex (MHC)

The Major Histocompatibility Complex (MHC) The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens

More information

Systemic immune response in whiplash injury and ankle sprain: elevated IL-6 and IL-10. Clin Immunol 2001 Oct;101(1):106-12

Systemic immune response in whiplash injury and ankle sprain: elevated IL-6 and IL-10. Clin Immunol 2001 Oct;101(1):106-12 1 Systemic immune response in whiplash injury and ankle sprain: elevated IL-6 and IL-10. Clin Immunol 2001 Oct;101(1):106-12 Kivioja J, Ozenci V, Rinaldi L, Kouwenhoven M, Lindgren U, Link H. FROM ABSTRACT:

More information